Asymchem Laboratories
Asymchem Laboratories, Inc. owns Asymchem Laboratories (Tianjin) Inc., a Chinese company established in 1998 that specializes in the research and development of pharmaceutical raw materials synthesis technology. This technology is integral to drug development and production, serving both large and medium-sized pharmaceutical companies in Europe and America. Asymchem Laboratories (Tianjin) Inc. boasts over 400 independent synthetic techniques and nearly 3,500 products, showcasing its extensive capabilities in the field. The company operates as a Contract Development and Manufacturing Organization (CDMO), offering solutions throughout the drug development and manufacturing process, including clinical and commercial stages. Its team consists of experienced professionals who have worked in significant pharmaceutical companies and American universities, contributing to its innovative approach and commercial application of pharmaceutical technology in both the Chinese mainland and international markets.
Bio-Link is a drug development company established in 2001 and headquartered in Shanghai, China. It specializes in providing bioprocessing solutions for the life science industry, focusing on the development and manufacturing of essential process equipment and consumables. These products are utilized in the production of vaccines, antibody drugs, cell therapy, gene therapy, and other biologics. Bio-Link's offerings encompass upstream cell culture, disposable dispensing reservoirs, downstream chromatography, ultrafiltration, and filtration, along with process development services. The company aims to deliver high-quality and innovative solutions that enhance the efficiency, safety, and competitiveness of the biopharmaceutical supply chain. Additionally, there are indications that Bio-Link may explore wearable technology aimed at elderly care.
Snapdragon Chemistry
Acquisition in 2022
Snapdragon Chemistry, Inc. specializes in continuous flow chemistry solutions tailored for the discovery and production of active pharmaceutical ingredients, intermediates, and materials. The company provides a range of services, including process development, reactor design and construction, portfolio optimization, and GMP manufacturing. By addressing the chemistry challenges faced by pharmaceutical, chemical, animal care, and material science sectors, Snapdragon Chemistry enables clients to create scalable synthetic processes. Founded in 2014 and based in Waltham, Massachusetts, the company was previously known as Firefly Chemistry, Inc. before rebranding in April 2015.
LaNova Medicines
Series A in 2021
LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.